Phase II randomized trial of neoadjuvant chemotherapeutic treatment (XELOX) followed by chemoradiotherapy (XELOX/RT) and surgery versus chemoradiotherapy followed by surgery and chemotherapy in patients with high risk rectal cancer

Trial Profile

Phase II randomized trial of neoadjuvant chemotherapeutic treatment (XELOX) followed by chemoradiotherapy (XELOX/RT) and surgery versus chemoradiotherapy followed by surgery and chemotherapy in patients with high risk rectal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Capecitabine; Oxaliplatin
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 02 Jun 2009 Final primary endpoint results presented at the 45th Annual Meeting of the American Society of Clinical Oncology
    • 02 Jun 2009 Status change from active, no longer recruiting to completed
    • 21 Oct 2008 Planned end date changed from 1 Nov 2008 to 1 Nov 2010 as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top